Dr. Maloney on Future Treatment With CAR T-Cell Therapy
David G. Maloney, MD, PhD, member of the Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses the future treatment landscape for chimeric antigen receptor (CAR) T-cell therapy.
David G. Maloney, MD, PhD, member of the Clinical Research Division, Fred Hutchinson Cancer Research Center, discusses the future treatment landscape for chimeric antigen receptor (CAR) T-cell therapy.
Patients need to be referred to treatment with CAR T-cell therapy at the appropriate time, states Maloney. The results will continue to be more beneficial as the studies move earlier in the disease course.
According to Maloney, it will take some time before CAR T-cell therapy is seen in oncology centers, as there is a learning curve associated with managing these patients.
